Evidence map›Paper›PMID 26261320›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Biologically active LIL proteins built with minimal chemical diversity.

Erin N Heim, Jez L Marston, Ross S Federman, Anne P B Edwards, Alexander G Karabadzhak, Lisa M Petti, Donald M Engelman, Daniel DiMaio

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Spiers Memorial Lecture: Analysis andFaraday discussions · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Designing minimalist membrane proteins.Biochemical Society transactions · 2019
    Review
  16. Article
  17. Small size, big impact: how studies of small DNA tumour viruses revolutionized biology.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Erin N HeimDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005;
Jez L MarstonDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005;
Ross S FedermanDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06520-8011;
Anne P B EdwardsDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005;
Alexander G KarabadzhakDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8024;
Lisa M PettiDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005;
Donald M EngelmanDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8024; Yale Cancer Center, New Haven, CT 06520-8028; daniel.dimaio@yale.edu donald.engelman@yale.edu.
Daniel DiMaioDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8024; Yale Cancer Center, New Haven, CT 06520-8028; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520-8040 daniel.dimaio@yale.edu donald.engelman@yale.edu.
Yale University · USYale Cancer Center · US

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007499 · NIGMS · YALE UNIVERSITY · PI CARLSON, JOHN R, REINKE, VALERIE J · 1985 to 2022
$13.9M
CELL TRANSFORMATION BY BOVINE PAPILLOMAVIRUSR01CA037157 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2019
$9.9M
TM INTERACTIONS IN MEMBRANE PROTEIN FOLDING AND FUNCTIONR01GM073857 · NIGMS · YALE UNIVERSITY · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2006 to 2023
$8.4M
CELL TRANSFORMATION BY BOVINE PAPILLOMAVIRUSR37CA037157 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL · 1992 to 1999
–
NCI NIH HHS CA037157NCI NIH HHS R01 CA037157NCI NIH HHS R37 CA037157NIGMS NIH HHS GM073857NIGMS NIH HHS R01 GM073857NIGMS NIH HHS T32 GM007223NIGMS NIH HHS T32GM007223NIGMS NIH HHS T32 GM007499NIGMS NIH HHS T32GM007499
6 · The paper itself

Abstract

We have constructed 26-amino acid transmembrane proteins that specifically transform cells but consist of only two different amino acids. Most proteins are long polymers of amino acids with 20 or more chemically distinct side-chains. The artificial transmembrane proteins reported here are the simplest known proteins with specific biological activity, consisting solely of an initiating methionine followed by specific sequences of leucines and isoleucines, two hydrophobic amino acids that differ only by the position of a methyl group. We designate these proteins containing leucine (L) and isoleucine (I) as LIL proteins. These proteins functionally interact with the transmembrane domain of the platelet-derived growth factor β-receptor and specifically activate the receptor to transform cells. Complete mutagenesis of these proteins identified individual amino acids required for activity, and a protein consisting solely of leucines, except for a single isoleucine at a particular position, transformed cells. These surprisingly simple proteins define the minimal chemical diversity sufficient to construct proteins with specific biological activity and change our view of what can constitute an active protein in a cellular context.

Indexed as

Amino Acid SequenceIsoleucineLeucineMolecular Sequence DataProteinsIsoleucineLeucineProteinsE5 proteinoncogenePDGF receptorsynthetic biologytraptamer

Identifiers

PMID26261320
PMCPMC4553812
OpenAlexW1930157745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.